+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Bullous Pemphigoid Market Report and Forecast 2024-2032 - Product Thumbnail Image

Bullous Pemphigoid Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
From
Beta-1 Receptors Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta-1 Receptors Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Electrocardiograph (ECG) Market Outlook, 2028 - Product Thumbnail Image

Electrocardiograph (ECG) Market Outlook, 2028

  • Report
  • November 2023
  • 174 Pages
  • Global
From
From
Pancreatic Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 4317 Pages
  • Global
From
From
Epidermal Growth Factor Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Epidermal Growth Factor Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Rare Disease Diagnostics Market Report 2025 - Product Thumbnail Image

Rare Disease Diagnostics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Red Biotechnology Market 2024-2028 - Product Thumbnail Image

Red Biotechnology Market 2024-2028

  • Report
  • December 2023
  • 166 Pages
  • Global
From
Loading Indicator